Millie Capital Management’s Novartis NVS Stock Holding History

Millie Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-17,364	Closed	-$1.23M	–	80
2016 Q3	$1.23M	Sell	17,364 -1,914	-10%	-$139K	1.35%	28
2016 Q2	$1.43M	Buy	19,278 +2,232	+13%	+$154K	1.51%	27
2016 Q1	$1.11M	Hold	17,046	–	–	1.19%	35
2015 Q4	$1.31M	Sell	17,046 -446	-3%	-$35.4K	1.37%	34
2015 Q3	$1.44M	Buy	17,492 +251	+1%	+$22.3K	1.31%	35
2015 Q2	$1.52M	Hold	17,241	–	–	1.4%	31
2015 Q1	$1.52M	Buy	17,241 +57	+0.3%	+$5.06K	1.42%	32
2014 Q4	$1.43M	Buy	+17,184	New	+$1.42M	1.48%	31

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Millie Capital Management's NVS Position: Q4 2016 in Review

Millie Capital Management sold out of Novartis (NVS) in Q4 2016, closing a stake of 17,364 shares — an estimated $1.23M sold.

Millie Capital Management first reported a position in NVS in Q4 2014 and held it in 8 quarters. The position peaked at $1.52M in Q1 2015. 904 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

Millie Capital Management reported no remaining Novartis position as of Q4 2016 after selling out during the quarter.
Millie Capital Management sold 17,364 Novartis shares in Q4 2016, an estimated $1.23M.
Millie Capital Management first reported a position in Novartis in Q4 2014 and held it in 8 quarters.
Millie Capital Management's Novartis position peaked at $1.52M in Q1 2015.
904 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on Millie Capital Management's 13F filing for Q4 2016, filed 10 Feb 2017.